Types of Aldosteronism

Other names you may see
Types
Causes
Common symptoms and signs
Diagnostic tests
Non-pharmacological treatments (therapies & others)
Drug treatments
Dietary molecular supplements
Regenerative / stem-cell drugs
Surgeries and procedures
Prevention strategies
When to see doctors
What to eat” and “what to avoid”
Frequently asked questions (FAQs)

Aldosteronism means your body makes too much aldosterone, a salt-controlling hormone from the adrenal glands (small glands that sit on top of each kidney). Aldosterone tells the kidneys to hold on to sodium and water and to release potassium. When aldosterone is too high for a long time, your body keeps extra salt and water, your blood pressure goes up, and your potassium level often goes down. This can cause resistant high blood pressure, muscle problems, heart rhythm changes, and higher risks for heart, kidney, and blood-vessel disease.

When the extra aldosterone is coming from the adrenal glands themselves, we call it primary aldosteronism (the classic name is Conn syndrome). When aldosterone is high because something else in the body is pushing the kidneys and adrenals to do that (for example, low kidney blood flow or strong fluid loss), we call it secondary hyperaldosteronism. In both situations, the end result is similar: too much aldosterone action.

Other names you may see

You may also see these terms used for the same condition or its subtypes: hyperaldosteronism, Conn syndrome (when caused by an aldosterone-producing adrenal tumor), primary aldosteronism (PA), idiopathic hyperaldosteronism, aldosterone-producing adenoma, unilateral adrenal hyperplasia, bilateral adrenal hyperplasia, familial hyperaldosteronism (types I–IV), glucocorticoid-remediable aldosteronism (GRA), aldosterone-producing carcinoma (rare cancer form), and for renin-driven forms: secondary hyperaldosteronism or renin-dependent hyperaldosteronism.

Types

Primary aldosteronism (PA). The adrenal glands make too much aldosterone on their own. Typical causes are a small benign tumor that makes aldosterone (adenoma), or both adrenals being overactive without a tumor (bilateral hyperplasia). Familial gene-linked forms also exist. Renin (the kidney hormone that normally drives aldosterone) is usually low in PA because the body is volume-expanded.
Secondary hyperaldosteronism. Something outside the adrenal glands turns on renin, which then drives up aldosterone. Examples include renal artery stenosis, advanced heart failure, cirrhosis with ascites, nephrotic syndrome, or strong salt/fluid loss (for example, diuretics, vomiting, or diarrhea). In these cases renin is high and aldosterone is high in response.

Causes

Primary (adrenal) causes

Aldosterone-producing adenoma (Conn syndrome). A small benign adrenal tumor makes aldosterone day and night, independent of normal controls.
Bilateral adrenal hyperplasia (idiopathic hyperaldosteronism). Both adrenal glands are enlarged or overactive, producing too much aldosterone without a discrete tumor.
Unilateral adrenal hyperplasia. One adrenal is overgrown and overactive; the other is normal.
Aldosterone-producing adrenocortical carcinoma. A rare cancer that secretes large amounts of aldosterone, often with severe hypertension and low potassium.
Familial hyperaldosteronism type I (glucocorticoid-remediable). A hereditary gene change makes aldosterone production respond to ACTH; low-dose steroids can suppress it.
Familial hyperaldosteronism type II. Familial tendency to primary aldosteronism not suppressible by steroids; several genes are implicated.
Familial hyperaldosteronism type III (KCNJ5 mutations). Causes aggressive overproduction; sometimes needs adrenal surgery.
Familial hyperaldosteronism type IV (CACNA1H and others). Calcium-channel gene changes increase aldosterone production.
Ectopic aldosterone-producing tumor (very rare). A tumor outside the adrenal (for example, in the kidney) produces aldosterone-like hormone.
Medication-related unmasking of PA. Discovery after starting drugs (for example, thiazide diuretics) that lower potassium and reveal an underlying aldosterone excess.

Secondary (renin-driven) causes

Renal artery stenosis. Narrowing of the kidney artery reduces kidney blood flow, raises renin, and drives aldosterone.
Renin-secreting tumor (juxtaglomerular cell tumor). A rare kidney tumor that releases renin, pushing aldosterone high.
Chronic kidney disease with ischemic changes. The kidneys sense low perfusion, increasing renin and aldosterone.
Congestive heart failure (low effective circulation). The body “thinks” volume is low, so renin and aldosterone rise.
Cirrhosis with ascites. Low effective blood volume triggers high renin and aldosterone to hold salt and water.
Nephrotic syndrome. Protein loss lowers effective blood volume and activates renin-aldosterone.
Severe dehydration or blood loss. Strong volume depletion turns on renin and secondarily aldosterone.
Diuretics (loop or thiazide). These medicines increase salt and water loss; the body compensates by raising renin and aldosterone.
Bartter or Gitelman syndromes. Genetic salt-wasting kidney disorders that push renin and aldosterone high.
Pregnancy or estrogen states (usually physiologic). RAAS activity rises; most people balance it, but it can reveal or worsen underlying aldosterone excess.

Common symptoms and signs

High blood pressure that is hard to control. Many people need three or more drugs; some are diagnosed after hypertension resists usual treatment.
Headaches. Can follow spikes in blood pressure.
Muscle weakness. Low potassium reduces muscle cell function, causing heaviness or true weakness.
Muscle cramps or spasms. Potassium and alkalosis changes make muscles more irritable.
Fatigue and low energy. Electrolyte imbalance and high blood pressure strain the body.
Palpitations or irregular heartbeat. Hypokalemia can trigger premature beats or other arrhythmias.
Numbness or tingling. Potassium shifts affect nerve and muscle membranes.
Frequent urination (polyuria). The kidneys lose the ability to concentrate urine well in chronic hypokalemia.
Increased thirst (polydipsia). Follows increased urination and electrolyte losses.
Nocturia. Urination overnight is common when the kidneys are affected.
Constipation. Low potassium slows gut muscle activity.
Muscle pains on exercise. Potassium shifts with exertion can cause cramps.
Mood changes (irritability, anxiety). Electrolyte changes and chronic hypertension can affect mood and sleep.
Occasional paralysis (rare, severe hypokalemia). Profound potassium loss can cause transient paralysis episodes.
Few or no symptoms. Some people feel fine; the only clue is high blood pressure or low potassium on tests.

Diagnostic tests

A) Physical examination

Repeated blood pressure measurements. Your clinician checks blood pressure on more than one day, sometimes in both arms and in seated and standing positions. Resistant or very high readings support the diagnosis and help track treatment effects.
Orthostatic vital signs. Blood pressure and heart rate are checked lying, sitting, and standing. In primary aldosteronism, volume is often expanded, so there is usually no big drop in standing pressure, unlike dehydration.
Target-organ check (heart, eyes, vessels). The clinician listens for heart enlargement signs, checks for pulse quality, and looks at the back of the eyes for hypertensive changes; this shows how long and how hard the blood pressure has hit the body.
Volume status exam. In primary aldosteronism, edema is often absent despite salt retention; in secondary forms like heart failure or cirrhosis, swelling, ascites, or crackles in the lungs may be present.

B) Manual / bedside and dynamic tests

Ambulatory or home blood pressure monitoring. A wearable cuff checks blood pressure all day and night to confirm persistent hypertension and to exclude “white-coat” effect.
Saline infusion suppression test. You receive a measured salt solution by vein; in healthy people this turns down aldosterone, but in primary aldosteronism aldosterone stays high, confirming autonomous production.
Oral sodium loading test. Over several days you eat a high-salt diet under supervision, then a 24-hour urine test measures aldosterone; failure to suppress points to primary aldosteronism.
Captopril challenge test. A single dose of captopril should lower aldosterone when the system is normal; persistent high aldosterone after the dose suggests primary aldosteronism.

C) Laboratory and pathological tests

Serum potassium. Low potassium (hypokalemia) supports the diagnosis, but normal potassium does not exclude it—many patients have normal values.
Serum sodium and chloride plus bicarbonate (CO₂). Sodium can be slightly high, and bicarbonate is often high (metabolic alkalosis) because aldosterone promotes hydrogen ion loss.
Plasma aldosterone concentration (PAC). A direct measure of aldosterone; drawn under standardized conditions to avoid false results.
Plasma renin activity or direct renin concentration. In primary aldosteronism, renin is suppressed; in secondary forms, renin is elevated.
Aldosterone-to-renin ratio (ARR). The key screening test: aldosterone divided by renin. A high ARR suggests primary aldosteronism and triggers confirmatory testing.
24-hour urinary aldosterone (often after salt loading). Measures total aldosterone output over a day; failure to suppress with high salt supports primary aldosteronism.
Kidney function tests (creatinine, eGFR) and urine albumin. Check for kidney damage from long-standing hypertension and guide safe treatment choices.
Genetic testing (selected patients). Looks for familial forms (for example, the chimeric CYP11B1/CYP11B2 gene in glucocorticoid-remediable aldosteronism, or KCNJ5, CACNA1H, CLCN2 variants) when onset is young, bilateral disease is present, or family history is strong.

D) Electrodiagnostic tests

12-lead electrocardiogram (ECG). Low potassium can show U-waves, prolonged QT, or other rhythm issues; long-standing hypertension can cause left-ventricular strain patterns.
Holter or event monitor (24-hour ECG). Used if palpitations or intermittent arrhythmias are suspected, helping relate symptoms to actual rhythm problems.

E) Imaging and localization tests

Adrenal CT scan. First-line imaging to look for an adrenal mass and to rule out cancer; also helps plan treatment. Note: small nodules are common with age, so CT cannot by itself tell you which side is overproducing.
Adrenal vein sampling (AVS). A catheter test in an interventional radiology suite that measures aldosterone directly from each adrenal vein. It is the gold standard to decide whether disease is one-sided (surgery can cure) or both-sided (medical therapy is best), especially in people over ~35 where incidental nodules are common.

Non-pharmacological treatments (therapies & others)

(Each item gives: description, purpose, mechanism.)

Daily salt reduction
Description: Cut down added salt, processed foods, fast foods, salty snacks, and salty pickles; aim for less than ~2 grams of sodium per day (about 5 grams of table salt).
Purpose: Lower blood pressure and reduce aldosterone-driven fluid retention.
Mechanism: Less sodium in the diet means the kidneys excrete more water; blood volume falls, pressure drops, and strain on the heart and arteries decreases.
DASH-style eating pattern
Description: A plate rich in vegetables, fruits, whole grains, beans, nuts, seeds; lean fish or poultry; minimal processed foods and added sugars.
Purpose: Improve blood pressure control and heart health.
Mechanism: High fiber and potassium foods support kidney salt loss and vessel relaxation; low saturated fat reduces stiffness of arteries.
Weight management
Description: Slow, steady weight loss if overweight (for example, 0.5 kg per week).
Purpose: Reduce blood pressure and improve treatment response.
Mechanism: Less visceral fat lowers sympathetic drive and hormonal signals that push the renin-angiotensin-aldosterone system (RAAS).
Regular aerobic exercise
Description: 150 minutes per week of brisk walking, cycling, or swimming, plus 2 days of light strength training.
Purpose: Lower blood pressure, improve energy, and reduce heart risks.
Mechanism: Exercise improves vessel flexibility, insulin sensitivity, and neurohormonal balance that influences RAAS activity.
Treat obstructive sleep apnea
Description: Screening and therapy (often CPAP) if snoring, daytime sleepiness, or witnessed apneas.
Purpose: Lower blood pressure and improve morning headaches or fatigue.
Mechanism: CPAP reduces nighttime sympathetic surges and RAAS activation that raise aldosterone.
Limit alcohol
Description: Avoid heavy drinking; keep intake low or zero.
Purpose: Prevent blood pressure spikes and fluid retention.
Mechanism: Alcohol can increase sympathetic tone and interfere with pressure control.
Stop smoking and vaping
Description: Use counseling, nicotine replacement, or medications as needed.
Purpose: Protect blood vessels and the heart.
Mechanism: Nicotine and smoke toxins stiffen arteries and worsen hypertension dynamics.
Avoid natural licorice and glycyrrhizin
Description: Check candies, teas, herbal mixes; avoid black licorice flavoring with real glycyrrhizin.
Purpose: Prevent “pseudo-aldosteronism.”
Mechanism: Glycyrrhizin blocks an enzyme that normally protects the body from cortisol acting like aldosterone, leading to sodium retention and low potassium.
Smart medication review
Description: With your clinician, review NSAIDs, certain birth control choices, decongestants (like pseudoephedrine), and other agents that raise BP.
Purpose: Remove medicine triggers that worsen hypertension.
Mechanism: Some drugs reduce kidney blood flow or stimulate pathways that raise pressure.
Adequate hydration (not excess)
Description: Drink enough water for thirst and light-yellow urine, but avoid over-drinking.
Purpose: Support kidney function without promoting swelling.
Mechanism: Balanced intake helps steady RAAS signals and kidney electrolyte handling.
Potassium-aware food choices
Description: Choose fruits/vegetables rich in potassium (bananas, oranges, kiwis, spinach, beans), unless your doctor says to limit potassium (for example, if kidney function is reduced or you take potassium-sparing drugs).
Purpose: Help correct aldosterone-driven potassium loss.
Mechanism: Dietary potassium supports blood vessel relaxation and natriuresis (salt loss).
Mind-body stress care
Description: Relaxed breathing, meditation, yoga, or tai chi for 10–20 minutes daily.
Purpose: Lower sympathetic tone and support BP control.
Mechanism: Calms stress hormones that interact with RAAS.
Home blood pressure monitoring
Description: Check BP at the same times daily with an arm cuff; record readings.
Purpose: Guide therapy adjustments sooner.
Mechanism: Trend data helps clinicians target aldosterone effects and med dosing.
Healthy sleep habits
Description: 7–9 hours, regular schedule, dark quiet room.
Purpose: Improve BP and daytime energy.
Mechanism: Stable sleep supports hormonal rhythm and autonomic balance.
Limit high-sodium mineral waters and sports drinks
Description: Pick low-sodium options; read labels.
Purpose: Avoid hidden salt loads.
Mechanism: Keeps sodium intake within targets to reduce volume expansion.
Reduce ultra-processed foods
Description: Choose fresh cooking and simple ingredients.
Purpose: Lower sodium, trans fats, and sugar.
Mechanism: Cuts drivers of inflammation and vascular stiffness.
Meal planning & label reading
Description: Plan weekly menus; aim for ≤300–400 mg sodium per serving where possible.
Purpose: Consistency in low-salt living.
Mechanism: Prevents “salt spikes” that counteract medicines.
Caffeine moderation
Description: Limit strong coffee/energy drinks if they spike your BP.
Purpose: Smooth BP patterns.
Mechanism: High caffeine can briefly increase pressure via adrenergic effects.
Diabetes and kidney care
Description: Keep glucose, A1c, and kidney health in goal range.
Purpose: Support safer BP control and potassium balance.
Mechanism: Healthier kidneys handle salt and potassium more predictably.
Team-based care and education
Description: Work with a clinician, dietitian, and (if needed) a sleep or kidney specialist.
Purpose: Improve outcomes and lower medication burden.
Mechanism: Coordinated care addresses all drivers of RAAS and BP.

Drug treatments

Spironolactone (mineralocorticoid receptor antagonist, MRA)
Dosage & time: 12.5–50 mg once daily to start; titrate up (some cases to 100–400 mg/day).
Purpose: First-line for primary aldosteronism when surgery isn’t done.
Mechanism: Blocks aldosterone at its receptor, causing salt/water loss and potassium retention.
Side effects: High potassium, low sodium, dizziness, breast tenderness/enlargement, menstrual changes, GI upset.
Eplerenone (MRA)
Dosage & time: 25–50 mg twice daily (or 50 mg once then increase).
Purpose: Alternative to spironolactone if side effects occur.
Mechanism: Selective aldosterone receptor blocker.
Side effects: High potassium, dizziness; less hormonal side effects than spironolactone.
Amiloride (potassium-sparing diuretic)
Dosage & time: 5–10 mg once or twice daily.
Purpose: Option if MRAs not tolerated or as add-on; useful in “pseudo” states with sodium retention.
Mechanism: Blocks epithelial sodium channels (ENaC) in kidney, promoting sodium loss.
Side effects: High potassium, nausea, headache.
Triamterene (potassium-sparing diuretic)
Dosage & time: 37.5–100 mg/day in divided doses.
Purpose: Similar to amiloride as add-on for BP control.
Mechanism: ENaC inhibition.
Side effects: High potassium, dizziness; rare kidney stones.
Thiazide-like diuretic (e.g., chlorthalidone)
Dosage & time: 12.5–25 mg each morning.
Purpose: BP control and volume reduction.
Mechanism: Increases sodium and water excretion in distal tubule.
Side effects: Low sodium, low potassium, high uric acid, higher glucose in some people.
ACE inhibitor (e.g., lisinopril)
Dosage & time: 10–40 mg once daily.
Purpose: Especially helpful in secondary aldosteronism from high renin.
Mechanism: Blocks angiotensin-converting enzyme, reducing angiotensin II and aldosterone release.
Side effects: Cough, high potassium, kidney function changes, rare angioedema.
ARB (e.g., losartan)
Dosage & time: 50–100 mg once daily.
Purpose: Alternative to ACE inhibitors; useful in renovascular or heart failure-related secondary aldosteronism.
Mechanism: Blocks angiotensin II type-1 receptor to lower aldosterone drive.
Side effects: High potassium, dizziness, kidney function changes.
Dihydropyridine calcium channel blocker (e.g., amlodipine)
Dosage & time: 5–10 mg once daily.
Purpose: Add-on BP control.
Mechanism: Relaxes vascular smooth muscle to lower resistance.
Side effects: Ankle swelling, flushing, headache.
Beta-blocker (e.g., metoprolol succinate)
Dosage & time: 25–200 mg once daily.
Purpose: Add-on for heart rate and BP control when indicated.
Mechanism: Lowers sympathetic tone; may reduce renin in some cases.
Side effects: Fatigue, cold hands, mood changes; avoid abrupt stop.
Direct renin inhibitor (aliskiren)
Dosage & time: 150–300 mg once daily.
Purpose: Selected cases of secondary aldosteronism where renin is very active.
Mechanism: Blocks renin, reducing the whole RAAS cascade.
Side effects: High potassium, diarrhea; avoid with ACEi/ARB in diabetes.
Loop diuretic (e.g., furosemide)
Dosage & time: 20–80 mg/day in divided doses (individualized).
Purpose: If there is edema or chronic kidney disease with volume overload.
Mechanism: Blocks sodium reabsorption in loop of Henle.
Side effects: Low potassium, dehydration, low magnesium, hearing issues at high doses.
Dexamethasone (familial hyperaldosteronism type I)
Dosage & time: Often 0.25–1 mg at night (specialist-directed).
Purpose: Suppress ACTH-driven aldosterone in glucocorticoid-remediable forms.
Mechanism: Feedback to pituitary to reduce ACTH and downstream aldosterone production.
Side effects: Sleep issues, mood changes, glucose rise, weight gain with higher/long use.
Potassium chloride supplements
Dosage & time: Individualized (for example, 10–40 mEq/day in divided doses), only if needed.
Purpose: Correct low potassium from aldosterone excess.
Mechanism: Replaces potassium losses.
Side effects: Stomach upset, high potassium if over-replaced or kidney function is reduced.
Magnesium supplementation (when low)
Dosage & time: Commonly 200–400 mg elemental magnesium daily.
Purpose: Support potassium stability and BP control.
Mechanism: Magnesium helps potassium move into cells and stabilizes heart rhythm.
Side effects: Diarrhea at high doses; adjust for kidney function.
Alpha-1 blocker (e.g., doxazosin)
Dosage & time: 1–8 mg once daily.
Purpose: Add-on option if BP remains high.
Mechanism: Relaxes arterial smooth muscle via alpha-1 blockade.
Side effects: Dizziness, first-dose lightheadedness.
Mineralocorticoid receptor–targeted combinations
Dosage & time: Low-dose MRA + thiazide or MRA + CCB (clinician-tailored).
Purpose: Improve BP and potassium balance with lower side effects per drug.
Mechanism: Complementary effects on salt handling and vascular tone.
Side effects: Reflect each component; labs monitored.
Statin (when indicated for ASCVD risk)
Dosage & time: As per risk (e.g., atorvastatin 10–40 mg nightly).
Purpose: Vascular protection in long-standing hypertension.
Mechanism: Lowers LDL and stabilizes plaques; indirectly supports BP goals.
Side effects: Muscle aches, liver enzyme changes (rare serious events are uncommon).
Hydralazine (selected resistant cases)
Dosage & time: 25–100 mg two to three times daily.
Purpose: Add-on vasodilator in resistant hypertension.
Mechanism: Direct arteriolar relaxation.
Side effects: Headache, fast heartbeat, fluid retention; lupus-like syndrome (rare, dose-dependent).
Clonidine (resistant BP, short-term bridge)
Dosage & time: 0.1–0.3 mg two to three times daily or patch weekly.
Purpose: Temporary control while optimizing core therapy.
Mechanism: Central alpha-2 agonist reduces sympathetic outflow.
Side effects: Dry mouth, sedation, rebound hypertension if abruptly stopped.
Finerenone (non-steroidal MRA; specialist use in CKD + diabetes)
Dosage & time: 10–20 mg once daily (per kidney function and potassium).
Purpose: Cardio-renal risk reduction; may help in RAAS-driven states.
Mechanism: Selective non-steroidal MR blockade.
Side effects: High potassium, kidney lab changes; requires close monitoring.

Dietary molecular supplements

These can modestly help with blood pressure or vascular health. Always discuss first, especially if you use MRAs or have kidney disease, because potassium can go too high.

Potassium citrate or potassium gluconate
Dose: Often 10–20 mEq/day if prescribed; individualized.
Function: Replaces potassium lost from aldosterone effect.
Mechanism: Restores serum potassium, supports vascular relaxation.
Magnesium glycinate or citrate
Dose: 200–400 mg elemental magnesium daily.
Function: Helps maintain normal potassium and blood pressure.
Mechanism: Supports cellular ion balance and smooth muscle relaxation.
Omega-3 fish oil (EPA/DHA)
Dose: 1–2 grams/day combined EPA+DHA.
Function: Modest BP lowering, anti-inflammatory vascular support.
Mechanism: Improves endothelial function and reduces vascular stiffness.
Coenzyme Q10
Dose: 100–200 mg/day.
Function: Small BP benefit and energy support in some patients.
Mechanism: Mitochondrial cofactor aiding endothelial health.
Beetroot powder or juice (dietary nitrate)
Dose: As labeled; often ~250–500 mL juice or equivalent powder.
Function: Short-term systolic BP reduction.
Mechanism: Nitrate → nitric oxide pathway causing vasodilation.
Hibiscus (roselle) tea extract
Dose: 1–2 cups/day or standardized extract per label.
Function: Mild BP lowering.
Mechanism: ACE-like inhibition and vasodilation effects.
Garlic extract (standardized allicin)
Dose: ~600–1200 mg/day standardized.
Function: Small BP reduction and lipid support.
Mechanism: Improves nitric oxide bioavailability and vasodilation.
Vitamin D (if deficient)
Dose: As per level (e.g., 1000–2000 IU/day or clinician-directed repletion).
Function: Correct deficiency that can worsen cardiovascular risk.
Mechanism: Hormonal effects on RAAS and vascular health.
L-citrulline
Dose: 3–6 grams/day in divided doses.
Function: Supports nitric-oxide-mediated vasodilation.
Mechanism: Precursor to L-arginine → increases NO synthesis.
Flaxseed (ground)
Dose: 1–2 tablespoons/day.
Function: Fiber and alpha-linolenic acid for mild BP and lipid benefit.
Mechanism: Improves endothelial function and reduces inflammation.

Regenerative / stem-cell drugs

Important safety disclaimer: There are no approved stem-cell, regenerative, or “immunity booster” drugs for treating aldosteronism. Because these are unproven and potentially risky, I cannot provide doses. Below are research-area examples only—not medical recommendations:

Experimental adrenal cortical cell regeneration approaches in animal models (no human dosing; not approved).
Mesenchymal stem cell therapies aimed at vascular or kidney repair (investigational; not for aldosteronism treatment).
Gene therapy concepts targeting aldosterone synthase (CYP11B2) regulation (pre-clinical, not available).
CRISPR-based correction of somatic mutations (e.g., KCNJ5) in aldosterone-producing adenomas (theoretical research area).
Tissue engineering or scaffold strategies for adrenal replacement (concept stage).
Immunomodulators to alter RAAS cross-talk (not established, not indicated).

Safer alternative: Use proven options—surgery for unilateral disease, MRAs, targeted BP therapy, and lifestyle changes—guided by an endocrinologist.

Surgeries and procedures

Laparoscopic unilateral adrenalectomy
Procedure: Keyhole surgery to remove one adrenal gland that has an aldosterone-producing adenoma or unilateral hyperplasia.
Why done: It is often curative for unilateral primary aldosteronism and can reduce the number of medicines needed.
Robotic adrenalectomy
Procedure: Similar to laparoscopic but with robotic assistance for precision in selected cases.
Why done: Surgeon preference or complex anatomy; goal is the same—remove the source of excess aldosterone.
Adrenal-sparing (partial) adrenalectomy
Procedure: Removes the adenoma while keeping healthy adrenal tissue.
Why done: Preserve adrenal function when technically possible and safe.
Adrenal vein sampling (AVS) – diagnostic procedure
Procedure: A catheter test that measures aldosterone from each adrenal vein.
Why done: To confirm whether excess aldosterone comes from one side (surgical) or both (medical therapy).
Renal artery angioplasty ± stenting
Procedure: Catheter-based widening of a narrowed kidney artery when renovascular disease drives secondary aldosteronism.
Why done: Improve kidney blood flow, lower renin drive, and help control blood pressure in carefully selected patients.

Prevention strategies

Keep daily sodium intake low and steady.
Maintain a healthy weight and stay physically active.
Treat sleep apnea if present.
Avoid licorice containing glycyrrhizin.
Review medicines that raise BP; minimize NSAIDs when possible.
Manage diabetes, lipids, and kidney health.
Limit alcohol and avoid smoking.
Monitor blood pressure at home and bring logs to visits.
Choose a DASH-style diet rich in plants and fiber.
Get timely evaluation if BP is resistant, potassium is low, or an adrenal nodule is found.

When to see doctors

See a healthcare professional as soon as possible if you have very high blood pressure (for example, ≥180/120 mmHg), chest pain, shortness of breath, weakness or paralysis, confusion, or fainting—these need urgent care. Make an appointment promptly if blood pressure stays high despite three medicines, if potassium is low, if you feel muscle cramps or weakness, if you have morning headaches, or if an imaging test found an adrenal nodule. People with high blood pressure at a young age, a family history of early strokes, or resistant hypertension should ask about screening for primary aldosteronism.

What to eat” and “what to avoid”

Eat more:

Fresh vegetables and fruits (especially leafy greens, berries, citrus).
Beans and lentils for fiber and potassium (if your doctor says potassium is okay).
Whole grains like oats, brown rice, and quinoa.
Low-fat dairy or fortified alternatives for calcium and protein.
Nuts and seeds in small portions for healthy fats.

Avoid or limit:

Processed and packaged foods with high sodium (soups, instant noodles, deli meats, chips).
Fast food and restaurant meals that are salt-heavy.
Salty condiments (soy sauce, fish sauce); choose low-sodium versions.
Black licorice products with glycyrrhizin.
Excess alcohol and large caffeine loads that spike BP.

Frequently asked questions (FAQs)

Is aldosteronism common?
It is more common than we used to think. Among people with hard-to-control blood pressure, a noticeable portion have primary aldosteronism.
What is the difference between primary and secondary aldosteronism?
Primary means the adrenal gland itself is overproducing aldosterone; secondary means another condition (like reduced kidney blood flow) is pushing aldosterone up through high renin.
Can aldosteronism be cured?
If it is unilateral (one adrenal making too much), surgery often cures or greatly improves it. If both glands are overactive or surgery is not an option, MRAs and lifestyle steps control it well.
Why is my potassium low?
Aldosterone tells the kidneys to waste potassium. Correcting the hormone problem and replacing potassium usually fixes this.
Do I always need surgery?
No. Many people do well on spironolactone or eplerenone. Surgery is considered if a single adrenal is the source and you are a good candidate.
How do doctors confirm the diagnosis?
They start with blood tests (aldosterone and renin), may do confirmatory suppression tests, imaging, and adrenal vein sampling to see which adrenal is responsible.
Will I take medicines forever?
If surgery cures unilateral disease, you may need fewer or no BP medicines. If both adrenals are overactive, long-term MRAs and BP meds are common and effective.
Are salt substitutes okay?
Many salt substitutes contain potassium chloride. If you are on MRAs or have kidney issues, these can raise potassium too high. Always ask your clinician first.
Can I exercise?
Yes. Regular moderate exercise helps. Avoid over-straining if potassium is very low until it is corrected.
What about pregnancy?
Management is individualized. Some drugs (like ACE inhibitors/ARBs) are not safe in pregnancy. You need an obstetrician and an endocrinologist to plan safe therapy.
What if I have an adrenal nodule on a scan?
Many nodules are harmless. In the setting of high aldosterone, doctors use tests like AVS to prove whether that nodule is the source before surgery.
Can licorice really raise my blood pressure?
Yes—natural licorice with glycyrrhizin can mimic aldosterone effects and cause high BP and low potassium.
Is potassium supplementation always needed?
Not always. If MRAs control aldosterone, potassium often normalizes. Supplements are used when levels remain low, under lab guidance.
What happens if aldosteronism is untreated?
Long-term uncontrolled aldosterone raises the risk of stroke, heart attack, atrial fibrillation, kidney disease, and heart enlargement.
Who should be screened for primary aldosteronism?
People with resistant hypertension, low potassium, hypertension at a young age, or high BP with an adrenal mass should discuss screening with their doctor.

Disclaimer: Each person’s journey is unique, treatment plan, life style, food habit, hormonal condition, immune system, chronic disease condition, geological location, weather and previous medical history is also unique. So always seek the best advice from a qualified medical professional or health care provider before trying any treatments to ensure to find out the best plan for you. This guide is for general information and educational purposes only. Regular check-ups and awareness can help to manage and prevent complications associated with these diseases conditions. If you or someone are suffering from this disease condition bookmark this website or share with someone who might find it useful! Boost your knowledge and stay ahead in your health journey. We always try to ensure that the content is regularly updated to reflect the latest medical research and treatment options. Thank you for giving your valuable time to read the article.